MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Common Equity (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Common Equity came in at -$5.8 million in Q4 2025, down 108.54% YoY from $67.8 million in Q4 2024, and up 85.72% on a QoQ basis from -$40.6 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Common Equity (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Common Equity data on file, last reported at -$5.8 million in Q4 2025.

  • Quarterly Common Equity fell 108.54% year-over-year to -$5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.8 million (down 108.54% YoY) and the FY2025 annual result came in at -$5.8 million, down 108.54% from the prior year.
  • Common Equity advanced to -$5.8 million in Q4 2025, from -$40.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $220.8 million in Q1 2021 to a low of -$40.6 million in Q3 2025.
  • A 5-year average of $107.1 million and a median of $119.7 million in 2022 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2024 — Common Equity surged 34.93% — and 2025, when it slumped 142.36%.
  • Tracing MGTX's Common Equity over 5 years: stood at $185.4 million in 2021, then sank by 36.5% to $117.7 million in 2022, then rose by 17.36% to $138.2 million in 2023, then tumbled by 50.91% to $67.8 million in 2024, then sank by 108.54% to -$5.8 million in 2025.
  • The last three Common Equity figures came in at -$5.8 million (Q4 2025), -$40.6 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 215.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 215.78 Mn
Dec 31, 2025 -5.79 Mn
Sep 30, 2025 -40.56 Mn
Jun 30, 2025 2.96 Mn
Mar 31, 2025 33.10 Mn
Dec 31, 2024 67.83 Mn
Sep 30, 2024 95.74 Mn
Jun 30, 2024 80.04 Mn
Mar 31, 2024 121.73 Mn
Dec 31, 2023 138.18 Mn
Sep 30, 2023 91.89 Mn
Jun 30, 2023 123.53 Mn
Mar 31, 2023 90.22 Mn
Dec 31, 2022 117.74 Mn
Sep 30, 2022 122.67 Mn
Jun 30, 2022 141.97 Mn
Mar 31, 2022 161.29 Mn
Dec 31, 2021 185.40 Mn
Sep 30, 2021 187.84 Mn
Jun 30, 2021 205.72 Mn